Minoryx Therapeutics Funding: $138M Raised, Series C (2022)
Minoryx Therapeutics is based in Mataró···Barcelona, Spain. It has raised $138M in total funding. Latest round: Series C.
Minoryx Therapeutics funding overview
Minoryx Therapeutics is based in Mataró···Barcelona, Spain. Minoryx Therapeutics has raised $138M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in May 2022. The round record for Minoryx Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Caixa Capital, Damià··Tormo, CDTI, Fund+, Ysios Capital, Caixa Capital Risc and 8 others. 14 distinct backers are named across the disclosed rounds.
Frequently asked about Minoryx Therapeutics funding
How much has Minoryx Therapeutics raised?
Minoryx Therapeutics has raised $138M in total disclosed funding across the rounds on record.
Who has invested in Minoryx Therapeutics?
Caixa Capital, Damià··Tormo, CDTI, Fund+, Ysios Capital, Caixa Capital Risc are named among the investors backing Minoryx Therapeutics.
What was the latest Minoryx Therapeutics funding round?
The most recent disclosed round is a Series C, announced in May 2022.
Where is Minoryx Therapeutics based?
Minoryx Therapeutics is based in Mataró···Barcelona, Spain.
When did Minoryx Therapeutics last raise?
The last disclosed Minoryx Therapeutics round closed in May 2022 at Series C.
We update the Minoryx Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Mataró···Barcelona and their backers are listed below.
